选择性支气管动脉插管药物治疗中晚期肺癌

Selective Bronchial Artery Catheterization Drug Infusion Therapy for Middle and Late Stage Lung Cancer

对84例中晚期肺癌进行选择性支气管动脉插管药物灌注。药物为LAK细胞,IL-2、卡铂、表阿霉素。结果显示,肿块明显消退12例占35.2％,部分消退18例占52.5％、无变化4例占12.7％、总有效率为87.3％。通过对支气管动脉插管技术,灌注疗法同其它治疗方法的优缺点进行比较,认为本疗法优于周围静脉给药且无严重并发症,副作用轻,不失为一种可供选择的治疗方法。

We have done selective bronchial artery catheterization, drug infusion therapy in 34 cases of middle and late stage lung cancer. The drugs infused were composed of lymphokin-activated killer (LAK) slice. interleukin-2(IL^2), carboplatin (CP) and dermoadriamycin (d ADM), The result showed:the mass completely dissappeared in 12 cases (35.2%), partial dissappeared in 18 cases (52.5 %), no change in 4 cases (12.7%), total effective rate was 87.3%. We compared the technology of bronchial artery catheterization drug, the infusion therapy with the other therapies resulting in superiority to the peripheral intravenous drup infusion therapy with mild side effect and no severe complication. Thus it may be considered as a method of choice for treatment.